5-Amino-1MQ (5-Amino-1-methylquinolinium) is a small molecule not a peptide that has gained attention for its novel metabolic mechanism
Lets discuss! (Source: @ Curios VC) #obesity #glp #biotech #biopharma Informative
Heart disease remains the worlds leading killer
Studies on GLP-1 medications highlight factors that negatively impact nutritional health and well-being, including loss of lean body weight (muscle mass), gastrointestinal side effects, reduced intake of protein, fiber and essential micronutrients, as well as significant decreases in daily calorie intake by as much as 40-50%
Compounded semaglutide and tirzepatide from licensed 503A compounding pharmacies bypass insurance entirely, which is why many patients use them while an appeal works its way through
Compounded medications are not reviewed or approved by the FDA as finished products and have not undergone FDA review for safety, effectiveness, or quality